Vasopressin Biology in Autism: From Biomarker to Treatment Target

Vasopressin Biology in Autism: From Biomarker to Treatment Target

Webinars / Vasopressin Biology in Autism: From Biomarker to Treatment Target
Overview
Summary
Speaker
Knowledge Quiz

Karen J. Parker, PhD, describes scientific barriers to progress in developing laboratory-based diagnostic tests and new medications for patients with autism. She considers the relative scientific merits of published findings from animal models of autism spectrum disorder by assessing their face and construct validity to the human disorder. Parker provides detailed scientific information on the biology of social deficits with an emphasis on vasopressin and oxytocin signaling pathways and biologically informed treatment trials in patients with autism.

Don't Miss Upcoming Webinars

Sign up to receive webinar updates and special resources from the Autism Research Institute.

Go to Top